Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest
Author:
Funder
National Cancer Center
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference33 articles.
1. Microtubules as a target for anticancer drugs;Jordan;Nat. Rev. Cancer,2004
2. Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer;Yang;Curr. Drug Targets,2010
3. Controversies in the management of adjuvant breast cancer with taxanes: review of the current literature;Araque Arroyo;Cancer Treat. Rev.,2011
4. Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes;Rivera;Am. J. Clin. Oncol.,2010
5. Prediction of chemotherapy response with platinum and taxane in the advanced stage of ovarian and uterine carcinosarcoma: a clinical implication of in vitro drug resistance assay;Matsuo;Am. J. Clin. Oncol.,2010
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel insights into the role of ion channels in cellular DNA damage response;Mutation Research/Reviews in Mutation Research;2024-01
2. Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer CellsviaStrong P-gp Inhibition;Anticancer Research;2023-02-28
3. The synergistic anticancer effect of salinomycin combined with cabazitaxel in CD44+ prostate cancer cells by downregulating wnt, NF-κB and AKT signaling;Molecular Biology Reports;2022-06
4. Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance;Anticancer Research;2022-04-30
5. JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells;International Journal of Molecular Sciences;2022-04-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3